Here are three key takeaways from the episode. 1. GLP-1 Medications Are a Tool, Not a Quick Fix. Originally developed to manage type 2 diabetes, GLP-1 receptor agonists like semaglutide have gained ...
With technical insight from AT&T’s Brad Steiner (Principle Strategist of Public Safety Technology) and operational perspective from Amherst, Mass. Fire Chief, Lindsay Stromgren, the discussion will ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results